drugset
drugset / Trial / NCT01319006

Relative Bioavailability Study for GSK1278863A

NCT01319006 ↗

Phase 1 Completed 30 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelBasic science

Summary

A randomized, open-label, 3-period crossover study.

Timeline

Start
2011-02-25
Primary completion
2011-04-18
Completion
2011-04-18

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1278863A Small molecule 100 mg Oral

Indications

anemia